The German pharmaceutical Boehringer Ingelheim plans to launch over the next three years oncology drugs from its pipeline in Brazil, and should focus on this segment. The company already makes clinical trial in the country.
See more: Valor Econômico
Boehringer focuses on oncology and targets BrazilThe German pharmaceutical Boehringer Ingelheim plans to launch over the next three years oncology drugs from its pipeline in Brazil, and should focus on this segment. The company already makes clinical trial in the country. See more: Valor Econômico Eurofarma increases partnership with CubaThe Brazilian pharmaceutical company Eurofarma extends the joint research and development - R&D of new biotech drugs with Cuban laboratories. The focus is on oncology products. See more: Valor Econômico |
|
|
|
|
|
|
| Page 1 of 55 |